Joinn Laboratories (China) (HKG:6127) reported 19.8 million yuan in third-quarter attributable profit, down 80% year on year, according to a Hong Kong bourse filing Thursday.
Earnings per share fell 77% to 0.03 yuan.
The drug research company's revenue fell nearly 35% year-on-year to 316.4 million yuan, figures showed.